HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 709-720 of 1,811
Other study type icon
TerminatedNCT01777048

Omega-3 Fatty Acids Supplementation in ADHD

Official study title

Augmenting the Effects of Methylphenidate: A Randomized, Placebo-Controlled Trial of Omega-3 Fatty Acids Supplementation in Children With Attention Deficit Hyperactivity Disorder

This study ended early.

In Basel
ADHDPlacebo comparisonAges 6–12
Countries
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Other study type icon
CompletedNCT07348562

Omega-3, Inflammation in ADHD With AI

Official study title

Omega-3 Fatty Acids, Inflammation and Attention Deficit Hyperactivity Disorder (ADHD) With AI (OmInADHDAI)- A Double-blind Randomized Controlled Trial of High Dose Omega-3 Fatty Acids in Children With ADHD With High Inflammation Status

This study has finished and is no longer accepting participants.

In Taichung
ADHDPlacebo comparisonAges 6–12
Countries
Taiwan
Sponsor
China Medical University Hospital
Behavioral study icon
CompletedNCT04086979

Parents as Friendship Coaches for Children With ADHD

Official study title

Parents as Friendship Coaches for Children With Attention-Deficit/Hyperactivity Disorder

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDBehavioural studyAges 6–11
Countries
Sponsor
University of British Columbia
Other study type icon
CompletedNCT06491160

Performance and FMRI BOLD Signal Changes in Impulsive Patients

Official study title

A Trial to Explore Performance and FMRI BOLD Signal Changes During Impulsivity Tasks in Impulsive Patients with Attention Deficit Hyperactivity Disorder and Borderline Personality Disorder

This study has finished and is no longer accepting participants.

In Berlin
Personality disorders, ADHDObservational studyAges 18–45
Countries
Germany
Sponsor
Simone Grimm
Drug study icon
CompletedNCT03618030

PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Official study title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Adult Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Adults With ADHD

This study has finished and is no longer accepting participants.

Multiple locations, including Bradenton
ADHDMedication studyAges 18–60
Countries
United States
Sponsor
Purdue Pharma, Canada
Behavioral study icon
CompletedNCT04138108

Psychoeducation in Parents of Children With ADHD

Official study title

The Effect of Psychoeducation on Stress in Parents of Children With Attention Deficit Hyperactivity Disorder (ADHD): A Randomized Controlled Study

This study has finished and is no longer accepting participants.

In Istanbul
ADHDInterventional studyAges 18–65
Countries
Türkiye
Sponsor
Saglik Bilimleri Universitesi

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.